In a groundbreaking class action, Wisner Baum LLP is invoking the civil RICO statute to hold Takeda and Eli Lilly accountable for allegedly concealing the cancer risks of diabetes drug Actos. The case ...

On August 17, the FDA approved Mylan’s new generic versions of Actos (pioglitazone), a once-daily oral tablet for the treatment of type 2 diabetes originally sold by Takeda. Mylan, Teva, and Ranbaxy ...

Appellate Court upholds decision in first-ever non-settlement national RICO class action lawsuit certified against a major pharmaceutical company, with potential damages exceeding $7 billion. The ...

A diabetes drug called pioglitazone not only regulates insulin but may also prevent prostate cancer recurrence by reprogramming cancer cells and slowing their growth. Credit: Stock Image A diabetes ...

This case concerned the diabetes medication ACTOS and whether its manufacturer, Takeda, violated antitrust laws by misdescribing its patent rights to the Food and Drug Administration, which in turn ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell–mediated severe cutaneous adverse reaction characterized by rash, fever, internal organ involvement, and systemic ...

Please provide your email address to receive an email when new articles are posted on . Patients with metformin-uncontrolled type 2 diabetes taking insulin and pioglitazone had greater risk for ...

As more people take the injectable weight-loss medication Wegovy, they should be aware of concerning reports of overdoses. That drug, more generally called semaglutide, can have unpleasant ...

Before he came to Washington Corrections Center, Vincent Burnett had gone six years without a epileptic seizure. He began suffering from them after he was shot in the head more than a decade ago, but ...

President Joe Biden and former President Donald Trump have seemingly found one issue they can agree on: Drug costs are too high. Each is crediting himself with price-busting policy successes that ...